Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells. - sprookjes - yvandenbroek - TriplyDB

Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells.

Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells.

http://www.wikidata.org/entity/Q34348322

about

MicroRNAs in the DNA Damage/Repair Network and Cancer Mechanisms of change in gene copy number The phosphorylation status of PAS-B distinguishes HIF-1alpha from HIF-2alpha in NBS1 repression MiR-210--micromanager of the hypoxia pathway PARP Inhibitors for Recurrent Ovarian Carcinoma: Current Treatment Options and Future Perspectives Progress toward overcoming hypoxia-induced resistance to solid tumor therapy Sapacitabine for cancer Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study.PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions Cellular and molecular mechanisms underlying oxygen-dependent radiosensitivity miR-210: More than a silent player in hypoxia MicroRNA regulation of DNA repair gene expression in hypoxic stress The yeast environmental stress response regulates mutagenesis induced by proteotoxic stress SUMOylation attenuates sensitivity toward hypoxia- or desferroxamine-induced injury by modulating adaptive responses in salivary epithelial cells Mutability and importance of a hypermutable cell subpopulation that produces stress-induced mutants in Escherichia coli.A microhomology-mediated break-induced replication model for the origin of human copy number variation.A Phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancer.Effects of acute versus chronic hypoxia on DNA damage responses and genomic instability.Hypoxic repression of endothelial nitric-oxide synthase transcription is coupled with eviction of promoter histones Dynamic regulation of Rad51 by E2F1 and p53 in prostate cancer cells upon drug-induced DNA damage under hypoxia Poly (ADP-ribose) polymerase inhibitor: an evolving paradigm in the treatment of prostate cancer.Hypoxic tumor microenvironment and cancer cell differentiation.Hypoxia and regulation of cancer cell stemness.Inhibition of poly(ADP-ribose) polymerase down-regulates BRCA1 and RAD51 in a pathway mediated by E2F4 and p130.Hypoxia/reoxygenation-induced mutations in mammalian cells detected by the flow cytometry mutation assay and characterized by mutant spectrum.In vivo profiling of hypoxic gene expression in gliomas using the hypoxia marker EF5 and laser-capture microdissection.Redox regulation of DNA repair: implications for human health and cancer therapeutic development.E2F1 promotes the recruitment of DNA repair factors to sites of DNA double-strand breaks Emergence of rationally designed therapeutic strategies for breast cancer targeting DNA repair mechanisms.Cyclin D1 integrates estrogen-mediated DNA damage repair signaling.Silencing of the DNA mismatch repair gene MLH1 induced by hypoxic stress in a pathway dependent on the histone demethylase LSD1 Molecular radiobiology: the state of the art Contextual synthetic lethality of cancer cell kill based on the tumor microenvironment.Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation Hypoxia as a biomarker for radioresistant cancer stem cells.Targeting abnormal DNA double strand break repair in cancer Oxidative stress diverts tRNA synthetase to nucleus for protection against DNA damage Cediranib, a pan-VEGFR inhibitor, and olaparib, a PARP inhibitor, in combination therapy for high grade serous ovarian cancer.EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling.Tumor hypoxia and genetic alterations in sporadic cancers.

P2860

Q21284509-04191EA4-568C-4FF6-96BE-EA5B10C8E071 Q22122003-5E1BAFB1-D7DC-417A-97BE-D34767721EA9 Q24306098-7C05D1C5-38FD-4FD7-B055-2F4E3057C5EE Q24628401-5357589C-CB7B-465B-82FB-F95AE112B342 Q26768661-0216074E-B0F0-4D88-A4AC-9F9E4105ABD7 Q26796405-FED6D30D-161D-47C5-B979-DDB40641CC25 Q27024675-CD273980-6502-41B4-B132-CC198787A2B0 Q27853070-A53B3F7E-27B4-43AB-B069-838F04296FE9 Q28071345-01C22087-AD75-43AE-A488-A8DF69376BA1 Q28087499-6BB9413B-6081-45E3-B010-5C4B00B207FB Q28306244-0877C1BE-CE0A-490A-BF51-DC5925EC013F Q28306694-179782D3-9B7C-4018-9106-34856DD4D417 Q28535023-8A56F0C0-2AC8-4A4F-8652-E299BD3339DE Q28572063-96984147-A7B6-443F-BB8C-4A1EA1C2938F Q33373675-C6F54F07-AA71-44AB-9EB2-CA742C66860E Q33404060-EB3F8B39-2B0F-4D41-996E-761523CDC43B Q33408735-61A4D40F-91B6-448D-A119-77A7B538F8DA Q33526747-A98597D1-484F-4BA6-9CE2-9D47782A2D2F Q33569829-BCF9BFCA-C3E1-4641-B6BD-56AB196D632F Q33584594-6B09B073-DF61-4033-806F-D6A8F29971F9 Q33621410-043F62A1-6176-47F7-A899-B376CE29FD11 Q33670820-4385DAE2-269A-4F9A-BB2F-05223412D2CF Q33705149-3644CB16-B899-49DE-B799-3187038C738E Q33719652-85F73597-1A02-431D-A8B6-4D9344211E93 Q33765194-5AD73893-6606-4FEF-8B44-C2A14E7FE80E Q33803567-5FD161FE-ADD8-45DB-BA39-C96D24A928E1 Q33830130-02F7F128-F072-42BF-A36B-E188759F2701 Q33879479-7C09EE70-271D-4427-89A4-24041657DACB Q33889555-BD246488-4D48-4FE8-BD06-8197B0CBC007 Q33916912-1006AA10-44A0-462C-A9CA-E86F4E80FB2A Q33954219-2785A4DD-282A-41A7-93DD-723F0A34D562 Q34124274-98C3840F-247C-4C8B-9B49-3F0F3B66EDD6 Q34300803-A20623C4-B7F1-4880-8021-51FF364FE43B Q34405013-9E9B128F-9492-4CBE-ACC3-26DFB365007F Q34420732-D72EC9CB-7DFF-4184-BBCF-FF3CCD1D0BB9 Q34457557-768475DC-FE10-46FA-A971-2420DEF758E5 Q34474232-F2D22854-C25A-469A-BB9F-208A806C7946 Q34514973-D2D784DC-7370-49FE-84B5-1645B4901816 Q34584872-185E4A4D-F9E1-4FA2-9E8F-91C4730175E5 Q34813119-2811C2A9-C2C3-4DEE-9200-4778A167C642

P2860

Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells.

http://www.wikidata.org/entity/Q34348322

description

2004 nî lūn-bûn

@nan

2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells.

@ast

Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells.

@en

Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells.

@nl

type

label

Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells.

@ast

Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells.

@en

Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells.

@nl

prefLabel

Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells.

@ast

Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells.

@en

Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells.

@nl

P1433

Q34348322-4F6F33A8-4624-499E-9FD8-091635F8D13E

P1476

Q34348322-D08D7885-7FCC-4BCB-AC0A-484F3573D7EF

P2093

Q34348322-1B4479B6-7CB9-4390-94E5-4B8022C1E7FE

Q34348322-1D423D2A-79E2-4194-8BC1-4A37E5C304ED

Q34348322-227465CB-A952-415A-95B6-8B78F8B1FB3F

Q34348322-598A183A-C90D-42F5-A14E-6C59B1323E9D

Q34348322-5E9EBB24-C2DE-4D73-8A17-5ECB1E5F6011

Q34348322-86DA74BF-9A0B-4171-AE83-1245AD1A651A

Q34348322-B8A56871-CEC1-44DE-80BC-2941055423FE

Q34348322-CDD9B266-85CD-4FD2-A71B-9ABB12D62B81

P2860

Q34348322-001ABCE7-FEF8-4F14-9695-AE7AF0C08F52

Q34348322-0909B9D2-1C9B-4F6B-8BF2-F80243DB7380

Q34348322-0A1012D4-4982-4F39-B5F6-41DF6C0D8A6A

Q34348322-0FDB1D25-FCBF-4165-85C6-ECE45D78E86B

Q34348322-18A73BFB-8D33-4FBD-B598-4EAA2EE3D093

Q34348322-18B1F8C1-1BB3-4A9B-96BB-56C8154C3D3D

Q34348322-2529F4F3-324C-4C25-AED0-A1B39A9C3942

Q34348322-29BB0EFF-0869-423F-A197-187411F04FFE

Q34348322-3887CDB4-9CAC-41D4-8B53-AE37C729CF47

Q34348322-38A4187D-BCD8-4CD1-8D3A-93A9226FEF85

P304

Q34348322-24174270-0982-4638-AFC4-57E8D3D3890E

P31

Q34348322-9E72B7EF-4483-47DE-BBB4-BDE39B6587BB

P356

Q34348322-80DDCC3C-1451-4E51-950F-97AF8CA2B95D

P407

Q34348322-C9602FD0-A4B3-4074-A66D-0325B7147250

P433

Q34348322-C2EABD0B-DA26-49A2-AB33-1ACA7A89BA97

P478

Q34348322-313BBA99-8FBE-4AF0-85A8-C434A3CA4DD3

P50

Q34348322-1CA9F46F-B735-4131-BFE8-19920D0EEF5C

Q34348322-985AA420-D77C-4070-B205-9C090BD7C5C1

P577

Q34348322-F4C22436-8C55-4B24-84B3-4B3DCFF28C25

P698

Q34348322-0E2B30F3-FACA-4C84-A66F-B89B59E24825

P921

Q34348322-E03998D3-23EE-4090-A2D1-815296431857

P932

Q34348322-85B0AE31-AE31-4B5F-A70D-441176119851

P356

MCB.24.19.8504-8518.2004

P1433

Molecular and Cellular Biology

P1476

Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells.

@en

P2093

Alice Meng

http://www.w3.org/2001/XMLSchema#string

Jennifer Woo

http://www.w3.org/2001/XMLSchema#string

Kårstein Måseide

http://www.w3.org/2001/XMLSchema#string

Matt E Roth

http://www.w3.org/2001/XMLSchema#string

Paul J Schaffer

http://www.w3.org/2001/XMLSchema#string

Paul Lizardi

http://www.w3.org/2001/XMLSchema#string

Peter M Glazer

http://www.w3.org/2001/XMLSchema#string

Ranjit S Bindra

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation and mechanisms of mammalian double-strand break repair

HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2

Chk2 phosphorylation of BRCA1 regulates DNA double-strand break repair

Hypoxia and oxidative stress. Tumour hypoxia--therapeutic considerations

Recombinational DNA repair and human disease

Cancer susceptibility and the functions of BRCA1 and BRCA2

The clonal evolution of tumor cell populations

A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers

P304

8504-8518

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/MCB.24.19.8504-8518.2004

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Robert G. Bristow

P577

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15367671

http://www.w3.org/2001/XMLSchema#string

P921

P932

516750

http://www.w3.org/2001/XMLSchema#string